Empirical Finance LLC Sells 151 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Empirical Finance LLC cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,955 shares of the medical equipment provider’s stock after selling 151 shares during the quarter. Empirical Finance LLC’s holdings in Intuitive Surgical were worth $6,240,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth $558,807,000. International Assets Investment Management LLC lifted its position in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after buying an additional 1,088,415 shares during the last quarter. FMR LLC lifted its position in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its position in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the last quarter. Finally, Strategic Financial Concepts LLC lifted its position in shares of Intuitive Surgical by 50,740.8% during the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after buying an additional 312,056 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,940 shares of company stock worth $3,333,485 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $582.98 on Friday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock’s 50-day moving average is $554.85 and its 200 day moving average is $513.96. The firm has a market cap of $207.65 billion, a price-to-earnings ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Wells Fargo & Company upped their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.